Interest in the network perspective of psychopathology is rapidly growing. This theory conceptualizes mental disorders as networks in which symptoms can trigger the presence of other symptoms [1]. It thus theorizes that symptoms actively generate other symptoms, and that this process can eventually lead to a full-blown mental disorder. If this is true, then symptom networks may be informative for clinical practice; symptoms that are more central in the network, and are thus assumed to influence many other symptoms, seem to be a logical starting point for intervention. However, in order to know how to optimally investigate the network perspective empirically, it is crucial to first establish whether different network approaches (cross-sectional vs. dynamic) result in similar conclusions.
22 September 2015 in International Journal of Methods in Psychiatric Research
Differences in within-person emotion dynamics may be an important source of heterogeneity in depression. To investigate these dynamics, researchers have previously combined multilevel regression analyses with network representations. However, sparse network methods, specifically developed for longitudinal network analyses, have not been applied. Therefore, this study used this approach to investigate population-level and individual-level emotion dynamics in healthy and depressed persons and compared this method with the multilevel approach. Time-series data were collected in pair-matched healthy persons and major depressive disorder (MDD) patients (n = 54). Seven positive affect (PA) and seven negative affect (NA) items were administered electronically at 90 times (30 days; thrice per day). The population-level (healthy vs. MDD) and individual-level time series were analyzed using a sparse longitudinal network model based on vector autoregression. The population-level model was also estimated with a multilevel approach. Effects of different preprocessing steps were evaluated as well. The characteristics of the longitudinal networks were investigated to gain insight into the emotion dynamics. In the population-level networks, longitudinal network connectivity was strongest in the healthy group, with nodes showing more and stronger longitudinal associations with each other. Individually estimated networks varied strongly across individuals. Individual variations in network connectivity were unrelated to baseline characteristics (depression status, neuroticism, severity). A multilevel approach applied to the same data showed higher connectivity in the MDD group, which seemed partly related to the preprocessing approach. The sparse network approach can be useful for the estimation of networks with multiple nodes, where overparameterization is an issue, and for individual-level networks. However, its current inability to model random effects makes it less useful as a population-level approach in case of large heterogeneity. Different preprocessing strategies appeared to strongly influence the results, complicating inferences about network density.
Our ability to accurately predict development and outcome of early expression of psychosis is limited. To elucidate the mechanisms underlying psychopathology, a broader, transdiagnostic approach that acknowledges the complexity of mental illness is required. The upcoming network paradigm may be fruitful here. In this study, we applied a transdiagnostic network approach to psychosis. Data pertain to the third wave (second follow-up) of a sample of adolescents originally recruited at age 7–8 years. At baseline, N = 347 children with auditory verbal hallucinations (AVH) and N = 347 control children were included. N = 293 of these N = 694 children participated in the second follow-up (mean age 18.9 years; 59% women). Participants completed the Community Assessment of Psychic Experiences (CAPE) and the Depression, Anxiety and Stress Scale (DASS-21). A specific type of network model, the Ising model, was applied to dichotomized CAPE and DASS items. Interconnections of experiences within the same domain were observed, as well as interconnections between experiences of multiple domains of psychopathology. Quantitative and qualitative differences in network architecture were found in networks of psychopathological experiences in individuals with or without AVH at age 7–8 years. Although adolescents with or without previous AVH did not differ in their current CAPE scores, differences in the interconnectedness of psychopathology items were still found, possibly mirroring a difference in psychosis liability. This study showed that it is possible to map transdiagnostic experiences of psychopathology as a network and that important information can be derived from this approach in comparison to regular approaches.
15 October 2015 in BMC Medical Research Methodology
Heterogeneity of psychopathological concepts such as depression hampers progress in research and clinical practice. Latent Variable Models (LVMs) have been widely used to reduce this problem by identification of more homogeneous factors or subgroups. However, heterogeneity exists at multiple levels (persons, symptoms, time) and LVMs cannot capture all these levels and their interactions simultaneously, which leads to incomplete models. Our objective is to briefly review the most widely used LVMs in depression research, illustrating their use and incompatibility in real data, and to consider an alternative, statistical approach, namely multimode principal component analysis (MPCA). We applied LVMs to data from 147 patients, who filled out the Quick Inventory of Depressive Symptomatology (QIDS) at 9 time points. Compatibility of the results and suitability of the LVMs to capture the heterogeneity of the data were evaluated. Alternatively, MPCA was used to simultaneously decompose depression on the person-, symptom- and time-level and to investigate the interactions between these levels. QIDS-data could be decomposed on the person-level (2 classes), symptom-level (2 factors) and time-level (2 trajectory-classes). However, these results could not be integrated into a single model. Instead, MPCA allowed for decomposition of the data at the person- (3 components), symptom- (2 components) and time-level (2 components) and for the investigation of these components’ interactions. Traditional LVMs have limited use when trying to define an integrated model of depression heterogeneity at the person, symptom and time level. More integrative statistical techniques such as MPCA can be used to address these relatively complex data patterns and could be used in future attempts to identify empirically-based subtypes/phenotypes of depression.
31 July 2023 in Pharmacoepidemiology and Drug Safety
Purpose: To assess sex differences in treatment patterns after metformin initiation among type 2 diabetes mellitus (T2D) patients.Methods: A cohort study was conducted using the Groningen Initiative to ANalyze Type 2 diabetes Treatment (GIANTT) primary care database. Patients aged ≥18 years initiating metformin were followed 2–5 years. Markov modeling was conducted to estimate treatment transition rates and calculate adjusted hazard ratios (aHR) with 95% confidence intervals (CI) comparing men with women adjusted for age, HbA1c level at initiation, and cardiovascular disease history. Kaplan–Meier analyses and Cox proportional‐hazards models were used to determine the time to and likelihood of getting treatment intensification. HbA1c levels at initiation and intensification were compared using Mann–Whitney U tests.Results: In total, 11 508 metformin initiators were included (50.1% women). The most common transition after initiation was a dose increase (probability women 0.52, men 0.59, no significant difference). Women were more likely than men to switch to any other non‐insulin hypoglycemic agent after initiation (aHR 1.66; 95% CI 1.31–2.12), after dose increase (aHR 1.48; 95% CI 1.10–1.98) and after dose decrease (aHR 2.64; 95% CI 1.28–5.46). Time to intensification was longer, time to switching was shorter, and HbA1c levels at initiation and intensification were lower for women than men.Conclusions: Sex disparities were observed in treatment transitions after metformin initiation. Women more often switched treatment than men, which suggest that prescribers acknowledge more tolerance or other problems for metformin in women. Men intensified treatment earlier and at higher HbA1c levels, indicative of a higher need for treatment intensification.